Indicator disease-guided testing for HIV - The next step for Europe?

HIV Medicine

Volumn 9, Issue SUPPL. 2, 2008, Pages 34-40

  Gazzard, Brian ^a   Clumeck, N ^b   D'arminio Monforte, A ^c   Lundgren, J D ^d  

^a CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b Department of Infectious Diseases ^*  (Belgium)

^c Istituto di Clinica Malattie Infettive e Tropicale   (Italy)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Audit; HIV testing; Indicator disease

Indexed keywords

ABNORMAL LABORATORY RESULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; BRAIN DISEASE; BURKITT LYMPHOMA; CANDIDIASIS; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; CLINICAL INDICATOR; COCCIDIOIDOMYCOSIS; CRYPTOCOCCOSIS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; ERYTHROCYTE SEDIMENTATION RATE; EUROPE; HEALTH CARE MANAGEMENT; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HERPES SIMPLEX; HERPES ZOSTER; HISTOPLASMOSIS; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; KAPOSI SARCOMA; LEUKOENCEPHALOPATHY; MONONUCLEOSIS; NEUTROPENIA; PNEUMOCYSTIS PNEUMONIA; PREGNANT WOMAN; PRIORITY JOURNAL; SCREENING TEST; SEXUALLY TRANSMITTED DISEASE; TOXOPLASMOSIS; TUBERCULOSIS; UTERINE CERVIX CANCER; WASTING SYNDROME;

AIDS SERODIAGNOSIS; AIDS-RELATED OPPORTUNISTIC INFECTIONS; EUROPE; FEMALE; HEALTH POLICY; HIV INFECTIONS; HUMANS; IMMUNE SYSTEM DISEASES; MALE; MANDATORY TESTING; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 44949136341     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2008.00592.x     Document Type: Article

References (58)

1. British Medical Association. Sexually transmitted infections (STI) update. http://www.bma.org.uk/ap.nsf/Content/stiup06 March 2006.
2. Delpierre C, Dray-Spira R, Cuzin L. Correlates of late HIV diagnosis: implications for testing policy. Int J STD AIDS 2007; 18: 312-317.
3. Dukers NH, Fennema HS, van den Snoek EM. HIV incidence and HIV testing behavior in men who have sex with men: Using three incidence sources, the Netherlands, 1984-2005. AIDS 2007; 21: 491-499.
4. European AIDS Clinical Society. Guidelines for the Clinical Management and Treatment of HIV-infected Adults in Europe. http://www.eacs.eu/guide/ index.htm 2007.
5. Girardi E, Sabin CA, d'Arminio Monforte A. Late diagnosis of HIV infection: Epidemiological features, consequences and strategies to encourage earlier testing. J Acquir Immune Defic Syndr 2007; 46 (Suppl. 1): S3-S8.
6. Centers for Disease Control and Prevention Revised recommendations for HIV of adults, adolescents and pregnant women in heath care settings. Morbid Mortal Weekly Rep 2006; 50: 1-16.
7. Schackman BR, Freedberg KA, Weinstein MC et al. Cost-effectiveness implications of the timing of antiretroviral therapy in HIV-infected adults. Arch Intern Med 2002; 162: 2478-2486.
8. Walensky RP, Weinstein MC, Kimmel AD et al. Routine human immunodeficiency virus testing: An economic evaluation of current guidelines. Am J Med 2005; 118: 292-300.
9. Kimmel AD, Goldie SJ, Walensky RP et al. Optimal frequency of CD4 cell count and HIV RNA monitoring prior to initiation of antiretroviral therapy in HIV-infected patients. Antiviral Ther 2005; 10: 41-52.
10. Wawer MJ, Gray RH, Sewankambo NK et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005; 191: 1403-1409.
11. Paltiel AD, Weinstein MC, Kimmel AD et al. Expanded screening for HIV in the United States - an analysis of cost-effectiveness. N Engl J Med 2005; 352: 586-595.
12. Sanders GD, Bayoumi AM, Sundaram V et al. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med 2005; 352: 570-585.
13. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbid Mortal Weekly Rep 1992; 41: 1-19.
14. Emery S, Abrams DI, Cooper DA et al. The evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial: rationale, design, and methods of ESPRIT. Controlled Clin Trials 2002; 23: 198-220.
15. World Health Organization. Scaling up prevention and treatment for TB and HIV. Report of the Fourth Global TB/HIV Working Group Meeting. http://www.who.int/tb/publications/en/aa_meeting_report_pp1_2.pdf
16. Health Protection Agency. Case reports (enhanced TB surveillance and National TB surveys). http://www.hpa.org.uk/infections/topics_az/tb/ epidemiology/tables.htm March 2007.
17. Melzer M, Warley A, Milburn H et al. Tuberculosis and HIV seroprevalence in Lambeth, Southwark and Lewisham, an area of South London. Respir Med 2003; 97: 167-172.
18. British HIV Association. Clinical Audit Report. http://www.bhiva.org/ files/file1030339.pdf 2004-2005
19. van der Werf MJ, Yegorova OB, Chechulin Y, Hasker E, Veen J, Turchenko LV. HIV testing practices of TB patients after introduction of a new testing policy in Kiev City, Ukraine. Int J Tuberc Lung Dis 2005; 9: 733-739.
20. Tortorano AM, Biraghi E, Astolfi A et al. European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia: Report from one Italian region. J Hosp Infect 2002; 51: 297-304.
21. Tortorano AM, Rigoni AL, Biraghi E et al. The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: Antifungal susceptibility patterns of 261 non-albicans Candida isolates from blood. J Antimicrob Chemother 2003; 52: 679-682.
22. Dromer F, Mathoulin-Pélissier S, Launay O et al. Determinants of disease presentation and outcome during cryptococcosis: The CryptoA/D study. PLoS Med 2007; 4: E21.
23. Bini EJ, Currie SL, Shen H et al. National multicenter study of HIV testing and HIV seropositivity in patients with chronic hepatitis C virus infection. J Clin Gastroenterol 2006; 40: 732-739.
24. Cacoub P, Renou C, Rosenthal E et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine (Baltimore) 2000; 79: 47-56.
25. Posthouwer D, Makris M, Yee TT et al. Progression to end-stage liver disease in patients with inherited bleeding disorders and hepatitis C: an international, multicenter cohort study. Blood 2007; 109: 3667-3671.
26. Raguin G, Rosenthal E, Cacoub P, Veyssier P, Piette JC, Micoud M. Hepatitis C in France: A national survey in the Departments of Internal Medicine and Infectious Diseases. The GERMIVIC (Joint Study Group on Hepatitis C virus of the French National Society of Internal Medicine and the French Society of Infectious Diseases). Eur J Epidemiol 1998; 14: 545-548.
27. Jebbari H, Alexander S, Ward H et al. Update on lymphogranuloma venereum in the United Kingdom. Sex Transm Infect 2007; 83: 324-326.
28. Hudson C, Bergenstrom A, Bell E, McCann E, Sherr L. The dilemma of antenatal HIV testing: What goes on in the European Community? J Roy Soc Med 1999; 92: 273-276.
29. Cocu M, Thorne C, Màtuşa R et al. Mother-to-child transmission of HIV infection in Romania: Results from an education and prevention programme. AIDS Care 2005; 17: 76-84.
30. Simpson W, Johnstone F, Goldberg D, Gormley S, Hart G. Antenatal HIV testing: Assessment of a routine voluntary approach. Br Med J 1999; 318: 1660-1661.
31. Scotto G, Saracino A, El-Hamed I et al. Epidemiology of tuberculosis in immigrant patients hospitalised in Infectious Diseases Units in Italy: multicentric study. Infez Med 2004; 12: 245-251 [Article in Italian].
32. Tattevin P, Casalino E, Fleury L, Egmann G, Ruel M, Bouvet E. The validity of medical history, classic symptoms, and chest radiographs in predicting pulmonary tuberculosis: Derivation of a pulmonary tuberculosis prediction model. Chest 1999; 115: 1248-1253.
33. Goss CH, Rubenfeld GD, Park DR et al. Cost and incidence of social comorbidities in low-risk patients with community-acquired pneumonia admitted to a public hospital. Chest 2003; 124: 2148-2155.
34. Vallès X, Marcos A, Pinart M et al. Hospitalized community-acquired pneumonia due to Streptococcus pneumoniae: Has resistance to antibiotics decreased? Chest 2006; 130: 800-806.
35. Tintelnot K, Lemmer K, Losert H, Schär G, Polak A. Follow-up of epidemiological data of cryptococcosis in Austria, Germany and Switzerland with special focus on the characterization of clinical isolates. Mycoses 2004; 47: 455-464.
36. ECMM. European Confederation of Medical Mycology (ECMM) prospective survey of cryptococcosis: Report from Italy. Med Mycol 2002; 40: 507-517.
37. Nolla-Salas J, Bosch J, Gasser I et al. Perinatal listeriosis: A population-based multicenter study in Barcelona, Spain (1990-1996). Am J Perinatol 1998; 15: 461-467.
38. Bauer TM, Lalvani A, Fehrenbach J et al. Derivation and validation of guidelines for stool cultures for enteropathogenic bacteria other than Clostridium difficile in hospitalized adults. J Am Med Assoc 2001; 285: 313-319.
39. García-Rodríguez JA, Martín Sánchez AM, Canut Blasco A et al. Incidence of Cryptosporidium sp. in patients treated in a general hospital. Technics for the identification of oocysts in feces. Med Clin (Barcelona) 1989; 93: 164-168 [Article in Spanish].
40. Doherty JF, Grant AD, Bryceson AD. Fever as the presenting complaint of travellers returning from the tropics. QJM 1995; 88: 277-281.
41. Bottieau E, Clerinx J, Van den Enden E et al. Infectious mononucleosis-like syndromes in febrile travelers returning from the tropics. J Travel Med 2006; 13: 191-197.
42. Larocca L, Leto D, Celesta BM et al. Prevalence of antibodies to HHV-8 in the general population and in individuals at risk for sexually transmitted and blood-borne infections in Catania, Eastern Sicily. Infez Med 2005; 13: 79-85.
43. Barone R, Ficarra G, Gaglioti D et al. Prevalence of oral lesions among HIV-infected intravenous drug abusers and other risk groups. Oral Surg Oral Med Oral Pathol 1990; 69: 169-173.
44. Felix DH, Wray D. The prevalence of oral candidiasis in HIV-infected individuals and dental attenders in Edinburgh. J Oral Pathol Med 1993; 22: 418-420.
45. Van de Perre P, Bakkers E, Batungwanayo J et al. Herpes zoster in African patients: An early manifestation of HIV infection. Scand J Infect Dis 1988; 20: 277-282.
46. Bayu S, Alemayehu W. Clinical profile of herpes zoster ophthalmicus in Ethiopians. Clin Infect Dis 1997; 24: 1256-1260.
47. Palexas GN, Welsh NH. Herpes zoster ophthalmicus: An early pointer to HIV-1 positivity in young African patients. Scand J Immunol Suppl 1992; 11: 67-68.
48. McGarrigle CA, Nicoll A. Prevalence of HIV-1 among attenders at sexually transmitted disease clinics: Analyses according to country of birth. Sex Transm Infect 1998; 74: 415-420.
49. Dunn D, Newell M-L, Ades A, Peckham C. Risk of human immunodeficiency virus type 1 transmission through breast-feeding. Lancet 1992; 340: 585-588.
50. Deblonde J, Claeys P, Temmerman M. Antenatal HIV screening in Europe: A review of policies. Eur J Public Health 2007; 17: 414-418. Epub 2007 September 17.
51. Simpson WM, Johnstone FD, Boyd FM et al. Uptake and acceptability of antenatal HIV testing: Randomised controlled trial of different methods of offering the test. Br Med J 1998; 316: 262-267.
52. Mulder-Folkerts DK, van den Hoek JA, van der Bij AK et al. Less refusal to participate in HIV screening among pregnant women in the Amsterdam region since the introduction of standard HIV screening using the opting-out method. Ned Tijdschr Geneeskd 2004; 148: 2035-2037.
53. Townsend CL, Cliffe S, Tookey PA. Uptake of antenatal HIV testing in the United Kingdom: 2000-2003. J Public Health (Oxford) 2006 Sep; 28: 248-252.
54. Laguna F, Garcia-Samaniego J, Soriano V et al. Gastrointestinal leishmaniasis in human immunodeficiency virus-infected patients: Report of five cases and review. Clin Infect Dis 1994; 19: 48-53.
55. Vaira D, Miglioli M, Menegatti M et al. Helicobacter pylori status, endoscopic findings, and serology in HIV-1-positive patients. Dig Dis Sci 1995; 40: 1622-1626.
56. Francis ND, Boylston AW, Roberts AH et al. Cytomegalovirus infection in gastrointestinal tracts of patients infected with HIV-1 or AIDS. J Clin Pathol 1989; 42: 1055-1064.
57. Bottieau E, Clerinx J, Van den Enden E et al. Infectious mononucleosis-like syndromes in febrile travelers returning from the tropics. J Travel Med 2006; 13: 191-197.
58. Brenner BG, Roger M, Routy JP et al. Quebec Primary HIV Infection Study Group. High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis 2007; 195: 951-959. Epub 2007 February 16.